|Articles|July 9, 2019

DSP Clinical Announces New Co-Monitoring Service

DSP Clinical, a full-service CRO managing Phase I to IV clinical trials across many therapeutic areas including infertility, endocrinology, urology, and gastrointestinal studies, announced a new co-monitoring service that provides flexible, cost-effective monitoring support to help clinical trials meet study timelines.

The service, which scales to fit the size, complexity, and speed of Phase I–IV research clinical trials in any therapeutic area, can provide back-up monitors who are trained and ready to help. DSP monitors are long-term CCRA-certified employees who are fluent in a variety of EDC systems.

Sponsors can elect to have full- or part-time monitoring help with tasks such as reviewing data, conducting pre-study visits, or preparing for site audits. DSP’s monitors step in as needed, working as an extension of the existing study team while minimizing overhead and lag time. The service is available immediately.

For more information, visit dspclinical.com


Related to this article

The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.